CSTL

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Castle Biosciences (CSTL) Earnings Date & Reports

Castle Biosciences Inc is a commercial-stage dermatological cancer company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CSTL is expected to report earnings to fall 118.28% to -5 cents per share on May 12

Castle Biosciences CSTL Stock Earnings Reports

Q1'25

Est.

$-0.06

Q4'24

Beat

by $0.31

Q3'24

Beat

by $0.08

Q2'24

Beat

by $0.58

Q1'24

Beat

by $0.23

The last earnings report on February 27 showed earnings per share of 31 cents, beating the estimate of 0 cents. With 289.59K shares outstanding, the current market capitalization sits at 608.02M.

View a ticker or compare two or three

Compare

CSTL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CSTL
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for CSTL (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients.

Industry MedicalSpecialties

Profile

Fundamentals

Details

Industry

N/A

Address

505 South Friendswood Drive

Phone

+1 866 788-9007

Employees

610

Web

https://www.castlebiosciences.com